Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lexaria Bioscience Corp 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 CAN

www.lexariabioscience.com P: 250-765-6424

Description:

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. Lexaria Bioscience Corp. is based in Kelowna, Canada.

Key Statistics

Overview:

Market Capitalization, $K 36,210
Enterprise Value, $K 34,860
Shares Outstanding, K 12,886
Annual Sales, $ 230 K
Annual Net Income, $ -6,660 K
Last Quarter Sales, $ 150 K
Last Quarter Net Income, $ -650 K
EBIT, $ -5,260 K
EBITDA, $ -5,110 K
60-Month Beta 0.99
% of Insider Shareholders 7.61%
% of Institutional Shareholders 13.06%
Float, K 11,905
% Float 92.39%
Short Volume Ratio 0.43

Growth:

1-Year Return 228.24%
3-Year Return -57.21%
5-Year Return 0.00%
5-Year Revenue Growth -46.51%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 04/09/24
Next Earnings Date 07/12/24 [--]
Earnings Per Share ttm -0.68
EPS Growth vs. Prev Qtr 53.85%
EPS Growth vs. Prev Year 72.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LEXX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -133.97%
Return-on-Assets % -118.89%
Profit Margin % -2,895.65%
Debt/Equity 0.00
Price/Sales 164.78
Price/Cash Flow N/A
Price/Book 5.19
Book Value/Share 0.50
Interest Coverage -1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar